Literature DB >> 22475625

α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion.

Hodaka Yamakado1, Yasuhiro Moriwaki, Nobuyuki Yamasaki, Tsuyoshi Miyakawa, Junko Kurisu, Kengo Uemura, Haruhisa Inoue, Makio Takahashi, Ryosuke Takahashi.   

Abstract

α-Synuclein (α-syn), the main component of Lewy bodies, was identified as a genetic risk factor for idiopathic Parkinson's disease (PD). As a model for PD, we generated human α-syn bacterial artificial chromosome transgenic mice (BAC tg mice) harboring the entire human α-syn gene and its gene expression regulatory regions. The α-syn BAC tg mice manifested decreased anxiety-like behaviors which may reflect non-motor symptoms of early PD, and they exhibited increased SERT expression that may be responsible for decreased anxiety-like behaviors. Our α-syn BAC tg mice could be a valuable tool to evaluate α-syn gene dosage effects in vivo.
Copyright © 2012 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475625     DOI: 10.1016/j.neures.2012.03.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  18 in total

1.  Manipulating the Mouse Genome Using Recombineering.

Authors:  Kajal Biswas; Shyam K Sharan
Journal:  Adv Genet Eng       Date:  2013-06-27

2.  Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.

Authors:  Silke Nuber; Daniel Tadros; Jerel Fields; Cassia Rose Overk; Benjamin Ettle; Kori Kosberg; Michael Mante; Edward Rockenstein; Margarita Trejo; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-08       Impact factor: 17.088

3.  A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Authors:  Silke Nuber; Florian Harmuth; Zacharias Kohl; Anthony Adame; Margaritha Trejo; Kai Schönig; Frank Zimmermann; Claudia Bauer; Nicolas Casadei; Christiane Giel; Carsten Calaminus; Bernd J Pichler; Poul H Jensen; Christian P Müller; Davide Amato; Johannes Kornhuber; Peter Teismann; Hodaka Yamakado; Ryosuke Takahashi; Juergen Winkler; Eliezer Masliah; Olaf Riess
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

4.  Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

Authors:  Meghan R Hennis; Marian A Marvin; Charles M Taylor; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2013-09-26       Impact factor: 5.996

Review 5.  Animal models of α-synucleinopathy for Parkinson disease drug development.

Authors:  James B Koprich; Lorraine V Kalia; Jonathan M Brotchie
Journal:  Nat Rev Neurosci       Date:  2017-07-13       Impact factor: 34.870

6.  Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.

Authors:  Eileen Ruth S Torres; Milos Stanojlovic; Moriel Zelikowsky; Jana Bonsberger; Sindalana Hean; Caitlin Mulligan; Leonie Baldauf; Sheila Fleming; Eliezer Masliah; Marie-Francoise Chesselet; Michael S Fanselow; Franziska Richter
Journal:  Neurobiol Dis       Date:  2021-08-11       Impact factor: 7.046

7.  Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.

Authors:  Shinya Okuda; Norihito Uemura; Masanori Sawamura; Tomoyuki Taguchi; Masashi Ikuno; Maiko T Uemura; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Neurotherapeutics       Date:  2021-12-21       Impact factor: 6.088

Review 8.  Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.

Authors:  Janina Grosch; Jürgen Winkler; Zacharias Kohl
Journal:  Front Cell Neurosci       Date:  2016-12-22       Impact factor: 5.505

9.  Time course and progression of wild type α-synuclein accumulation in a transgenic mouse model.

Authors:  David Amschl; Jörg Neddens; Daniel Havas; Stefanie Flunkert; Roland Rabl; Heinrich Römer; Edward Rockenstein; Eliezer Masliah; Manfred Windisch; Birgit Hutter-Paier
Journal:  BMC Neurosci       Date:  2013-01-09       Impact factor: 3.288

10.  Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.

Authors:  Susumu Hara; Shigeki Arawaka; Hiroyasu Sato; Youhei Machiya; Can Cui; Asuka Sasaki; Shingo Koyama; Takeo Kato
Journal:  Mol Biol Cell       Date:  2013-04-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.